MDT vs. ABT, ISRG, SYK, BSX, BDX, EW, DXCM, IDXX, RMD, and STE
Should you be buying Medtronic stock or one of its competitors? The main competitors of Medtronic include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Medtronic (NYSE:MDT) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, community ranking, analyst recommendations, dividends, institutional ownership and media sentiment.
Medtronic received 658 more outperform votes than Abbott Laboratories when rated by MarketBeat users. Likewise, 76.32% of users gave Medtronic an outperform vote while only 69.67% of users gave Abbott Laboratories an outperform vote.
82.1% of Medtronic shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 0.3% of Medtronic shares are owned by company insiders. Comparatively, 1.1% of Abbott Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Abbott Laboratories has a net margin of 13.96% compared to Medtronic's net margin of 11.36%. Abbott Laboratories' return on equity of 20.18% beat Medtronic's return on equity.
Abbott Laboratories has higher revenue and earnings than Medtronic. Medtronic is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.
Medtronic pays an annual dividend of $2.76 per share and has a dividend yield of 3.3%. Abbott Laboratories pays an annual dividend of $2.20 per share and has a dividend yield of 2.0%. Medtronic pays out 100.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories pays out 68.5% of its earnings in the form of a dividend.
Medtronic has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500.
In the previous week, Medtronic had 9 more articles in the media than Abbott Laboratories. MarketBeat recorded 25 mentions for Medtronic and 16 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 0.96 beat Medtronic's score of 0.80 indicating that Abbott Laboratories is being referred to more favorably in the news media.
Medtronic currently has a consensus price target of $93.00, indicating a potential upside of 10.61%. Abbott Laboratories has a consensus price target of $120.64, indicating a potential upside of 12.14%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Abbott Laboratories is more favorable than Medtronic.
Summary
Abbott Laboratories beats Medtronic on 14 of the 20 factors compared between the two stocks.
Get Medtronic News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Medtronic Competitors List
Related Companies and Tools
